| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00075197-199905000-00002 |
| P698 | PubMed publication ID | 10456248 |
| P2093 | author name string | Hasselgren PO | |
| P433 | issue | 3 | |
| P304 | page(s) | 201-205 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Current Opinion in Clinical Nutrition and Metabolic Care | Q15757962 |
| P1476 | title | Glucocorticoids and muscle catabolism | |
| P478 | volume | 2 |
| Q35599114 | 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes |
| Q35993669 | A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. |
| Q33804521 | Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions |
| Q35231710 | Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 |
| Q47720596 | Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats |
| Q46315965 | An integrative appraisal of the hormonal and metabolic changes induced by acute stress using king penguins as a model. |
| Q24555065 | Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy |
| Q36583817 | Atrophy and hypertrophy of skeletal muscles: structural and functional aspects |
| Q57049582 | Body condition and adrenal glucocorticoid activity affects metabolic marker and lipid profiles in captive female elephants in Thailand |
| Q42144502 | C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1 |
| Q36956035 | Calpain activity and muscle wasting in sepsis |
| Q37825936 | Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? |
| Q34996952 | Catabolic response to stress and potential benefits of nutrition support. |
| Q25257831 | Chaperoning steroid hormone signaling via reversible acetylation |
| Q96428227 | Characterization of stress response involved in chicken myopathy |
| Q41460376 | Corticosteroid effects on ventilator-induced diaphragm dysfunction in anesthetized rats depend on the dose administered |
| Q36941816 | Corticosteroid-induced adverse events in adults: frequency, screening and prevention |
| Q34115660 | Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation |
| Q51802118 | Creatine intake attenuates corticosteroid-induced impairment of voluntary running in hamsters. |
| Q37859010 | Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery |
| Q54613942 | Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics. |
| Q33980095 | Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes |
| Q33840413 | Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A(2)-dependent mechanism. |
| Q28570470 | Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent |
| Q44227855 | Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats |
| Q39702137 | Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors. |
| Q35207855 | Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors |
| Q33625146 | Effect of antenatal betamethasone on maternal and fetal amino acid concentration. |
| Q28548658 | Effects of Dexamethasone and Insulin Alone or in Combination on Energy and Protein Metabolism Indicators and Milk Production in Dairy Cows in Early Lactation - A Randomized Controlled Trial |
| Q55087020 | Effects of chronic dexamethasone administration on hyperglycemia and insulin release in goats. |
| Q44238910 | Effects of creatine supplementation on muscle wasting and glucose homeostasis in rats treated with dexamethasone |
| Q84193194 | Effects of dexamethasone on the expression of beta(1)-, beta (2)- and beta (3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats |
| Q47401468 | Extracellular polysaccharides purified from Aureobasidium pullulans SM‑2001 (Polycan) inhibit dexamethasone‑induced muscle atrophy in mice |
| Q30405450 | Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure |
| Q29619282 | Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy |
| Q83150780 | Gender influences neuromuscular adaptations to muscle unloading |
| Q34032716 | Gene expression during normal and FSHD myogenesis |
| Q42279231 | Ginsenoside Rg1 from Panax ginseng enhances myoblast differentiation and myotube growth |
| Q36956280 | Glucocorticoid effects on adiponectin expression |
| Q38889124 | Glucocorticoid therapy and ocular hypertension |
| Q38148190 | Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment |
| Q44422727 | Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression |
| Q97650585 | Glucocorticoids and activity in free-living arctic ground squirrels: Interrelationships between weather, body condition, and reproduction |
| Q36491244 | Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism |
| Q41837322 | Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. |
| Q39492090 | Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy |
| Q40780492 | Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents downregulation of NF-kappaB. |
| Q46714303 | Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy |
| Q35210556 | Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review |
| Q38017953 | Implications of glucocorticoid therapy in idiopathic inflammatory myopathies |
| Q37689760 | Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis |
| Q35097627 | Increased transcription of ubiquitin-proteasome system components: molecular responses associated with muscle atrophy |
| Q35798922 | Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury |
| Q44964500 | Influence of corticosteroids on myonuclear domain size in the rat diaphragm muscle |
| Q28512771 | Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo |
| Q44399900 | Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters |
| Q38430443 | Integration of miRNA and mRNA expression profiles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia. |
| Q51712674 | Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus. |
| Q34428893 | LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. |
| Q64229241 | LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K/AKT pathway |
| Q36454351 | Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness |
| Q38165143 | Mechanisms modulating skeletal muscle phenotype |
| Q34569547 | Microarray gene expression analysis in atrophying rainbow trout muscle: a unique nonmammalian muscle degradation model |
| Q38207093 | Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues |
| Q37618225 | Mitochondrial gene profiling: translational perspectives |
| Q38628354 | Molecular pathophysiology of hepatic glucose production |
| Q44904396 | Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. |
| Q34802678 | Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys |
| Q36647399 | Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy. |
| Q34629780 | Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction. |
| Q50283542 | Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm |
| Q61448501 | Omega-3 multiple effects increasing glucocorticoid-induced muscle atrophy: autophagic, AMPK and UPS mechanisms |
| Q34575428 | PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription |
| Q33369410 | Pathophysiologic response to severe burn injury |
| Q42011965 | Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy |
| Q26824503 | Pharmacology of manipulating lean body mass |
| Q40527269 | Postnatal glucocorticoid exposure alters the adult phenotype |
| Q64941154 | Protective Effect of Pyropia yezoensis Peptide on Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes. |
| Q60907851 | Protein Prevents Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes |
| Q58749734 | Protein Supplementation Prevents Dexamethasone-Induced Muscle Atrophy in C57BL/6 Mice |
| Q41352047 | Risk-averse personalities have a systemically potentiated neuroendocrine stress axis: A multilevel experiment in Parus major. |
| Q36796704 | Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats |
| Q33988273 | Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation |
| Q36028202 | Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass |
| Q46879724 | Seasonal variation in glucocorticoid and mineralocorticoid receptors in metabolic tissues of the house sparrow (Passer domesticus). |
| Q34215201 | Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle |
| Q28574576 | Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle |
| Q42949695 | Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle |
| Q39751365 | Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism |
| Q73208228 | Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle |
| Q37244100 | Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer |
| Q38686236 | Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy |
| Q47335702 | Temporal dynamics of the HPA axis linked to exploratory behavior in a wild European songbird (Parus major). |
| Q40559475 | The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors |
| Q64254406 | The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis |
| Q91091329 | The difference a day makes: Breeding remodels hearing, hormones and behavior in female Cope's gray treefrogs (Hyla chrysoscelis) |
| Q34273469 | The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes. |
| Q24673024 | The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn |
| Q37120241 | The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. |
| Q36387571 | The immunological consequences of injury |
| Q24312951 | The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy |
| Q43482401 | The leaking anterior resection and the management of SIRS, MODS and CHAOS. |
| Q36860334 | The role of microRNAs in skeletal muscle health and disease |
| Q33910776 | Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration |
| Q47800428 | Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis. |
| Q41565387 | Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone |
| Q40321294 | Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression |
| Q28582049 | Tripeptidyl-peptidase II expression and activity are increased in skeletal muscle during sepsis |
| Q64113495 | Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer |
| Q38064733 | Understanding the mechanisms and treatment options in cancer cachexia |
| Q41510683 | Voluntary exercise improves metabolic profile in high-fat fed glucocorticoid-treated rats |
| Q45712556 | Wound healing reduces stress-induced immune changes: evidence for immune prioritization in the side-blotched lizard |
| Q28540883 | β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat |
Search more.